About the Author
Gordon Krass oversees the workings of IntelliGuard, an IoT technology company utilizing RFID to manage critical medications used in the hospital and Life Science settings.
Gordon brings more than 25 years of experience with start-up and Fortune 500 companies in the medical device and telecommunications industries as both an executive and consultant. Just prior to joining IntelliGuard, he spent 4.5 years as President and then Chief Client Officer of NobelBiz, a telecommunications and software company. Prior to joining NobelBiz, Gordon spent over 16 years with IVAC Corporation (Alaris Medical/Carefusion), where he served as Vice President of Marketing and Sales, among other positions. Previously, Gordon spent 7 years as Vice President of Sales and a member of the leadership team at LMA North America, a medical device company that introduced new technology into the anesthesia market.
Fresenius Kabi recognizes the importance of continually innovating the pharmaceutical industry with auto-identification technologies to support accurate, efficient data collection and safer patient care. We value the opinions of industry leaders in this field working to achieve this common goal.
The opinions expressed in this article are those of the authors. They do not purport to reflect the opinions or views of the company they represent or Fresenius Kabi USA, LLC.